BA
GILD icon

Boston Advisors’s Gilead Sciences GILD Stock Holding History

Boston Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$916K Sell
14,460
-206
-1% -$13.5K 0.05% 401
2019
Q2 		$991K Sell
14,666
-394
-3% -$25.9K 0.05% 359
2019
Q1 		$979K Sell
15,060
-4,622
-23% -$307K 0.05% 347
2018
Q4 		$1.23M Buy
19,682
+2,772
+16% +$194K 0.07% 278
2018
Q3 		$1.31M Sell
16,910
-2,261
-12% -$171K 0.06% 329
2018
Q2 		$1.36M Sell
19,171
-1,224
-6% -$86.4K 0.03% 322
2018
Q1 		$1.54M Sell
20,395
-45,508
-69% -$3.62M 0.04% 304
2017
Q4 		$4.72M Sell
65,903
-306,527
-82% -$23.3M 0.1% 226
2017
Q3 		$30.2M Sell
372,430
-17,790
-5% -$1.36M 0.68% 28
2017
Q2 		$27.6M Sell
390,220
-116,205
-23% -$7.73M 0.64% 27
2017
Q1 		$34.4M Sell
506,425
-30,115
-6% -$2.12M 0.81% 19
2016
Q4 		$38.4M Sell
536,540
-133,621
-20% -$9.93M 0.92% 16
2016
Q3 		$53M Sell
670,161
-58,941
-8% -$4.79M 1.31% 9
2016
Q2 		$60.8M Sell
729,102
-9,549
-1% -$847K 1.52% 7
2016
Q1 		$67.9M Buy
738,651
+89,302
+14% +$8.05M 1.67% 6
2015
Q4 		$65.7M Buy
649,349
+389,321
+150% +$40.5M 1.54% 6
2015
Q3 		$25.5M Buy
260,028
+71,361
+38% +$7.93M 0.96% 11
2015
Q2 		$22.1M Buy
188,667
+10,846
+6% +$1.19M 0.92% 18
2015
Q1 		$17.4M Sell
177,821
-4,775
-3% -$485K 0.69% 37
2014
Q4 		$17.2M Sell
182,596
-14,440
-7% -$1.49M 0.73% 42
2014
Q3 		$21M Buy
197,036
+380
+0.2% +$37.2K 0.89% 28
2014
Q2 		$16.3M Sell
196,656
-21,970
-10% -$1.71M 0.7% 39
2014
Q1 		$15.5M Buy
218,626
+45,037
+26% +$3.53M 0.69% 43
2013
Q4 		$13M Sell
173,589
-22,758
-12% -$1.58M 0.62% 51
2013
Q3 		$12.3M Sell
196,347
-1,441
-0.7% -$86.1K 0.66% 51
2013
Q2 		$10.1M Buy
+197,788
New +$10.3M 0.49% 69

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boston Advisors's GILD Position: Q3 2019 in Review

Boston Advisors reduced its Gilead Sciences (GILD) stake by 1.4% in Q3 2019, selling an estimated $13.5K and leaving 14,460 shares worth $916K. The position accounts for 0.05% of the portfolio, ranked #401.

Boston Advisors first reported a position in GILD in Q2 2013 and has held it in 26 quarters since. The position peaked at $67.9M in Q1 2016. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Boston Advisors held 14,460 shares of Gilead Sciences worth $916K as of Q3 2019.
  • Boston Advisors sold 206 Gilead Sciences shares in Q3 2019, an estimated $13.5K.
  • Gilead Sciences made up 0.05% of Boston Advisors's portfolio in Q3 2019, its #401 holding.
  • Boston Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 26 quarters since.
  • Boston Advisors's Gilead Sciences position peaked at $67.9M in Q1 2016.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.